Table 1_Comprehensive safety assessment of donepezil: pharmacovigilance analysis based on the FDA adverse event reporting system.xlsx

Table 1_Comprehensive safety assessment of donepezil: pharmacovigilance analysis based on the FDA adverse event reporting system.xlsx

Background<p>Alzheimer’s disease (AD) has a growing global prevalence, and the need for safe and effective treatments is urgent. Donepezil is commonly used therapeutic agents for AD but has safety controversies. The objective of this study was to thoroughly evaluate donepezil’s adverse event p...

Full description

Saved in:
Bibliographic Details
Main Author: Shuo Li (143148) (author)
Other Authors: Wenlong Qian (22608053) (author), Zhuo Zhang (72795) (author), Yonghua Chen (602708) (author), Xiaoxiao Hou (18584988) (author), Bingjie Min (22608059) (author), Hui Zhou (13228) (author), Xinyu Zhu (579718) (author), Jia Ling (12716231) (author), Wenming Yang (4017086) (author), Shijian Cao (9573488) (author)
Published: 2025
Subjects:
Neurology and Neuromuscular Diseases
donepezil
FDA adverse event reporting system
disproportionality analyses
pharmacovigilance
adverse event
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items